Thousands of migraine sufferers are to get relief after the National Institute for Health and Care Excellence’s (Nice) recommended a new treatment to the NHS. The pill, named Rimegepant, will be an option for preventing migraines in up to 145,000 adults, if previous treatments have failed.
Nice estimates that there are 190,000 migraine attacks experienced every day in England and it is classified as a neurological disease that can leave sufferers debilitated for days. A migraine is typically characterised by suffering very bad headache with nausea, difficulty speaking, sensitivity to light and temporarily sight loss.
Beta-blockers, antidepressants, injections and epilepsy medicine are currently being used to treat the headaches, but these can have significant side-effects and don't always work.
